 - Known active acute hepatitis and confirmed diagnosis of Human Immunodeficiency Virus HIV infection. HIV-positive patients on combination antiretroviral therapy are ineligible. These patients are at increased risk of lethal infections when treated with marrow-suppressive therapy. 